Showing results (1641-1650 of 1,711) with videos related to
Sort By:
Pageof 172
Nature Medicine|August 23, 2024
Role of anticoagulation therapy in modifying stroke risk associated with new-onset atrial fibrillation after non-cardiac surgeryOmid Azimaraghi, Maíra I Rudolph, Karuna Wongtangman, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.Journal of the American College of Cardiology|May 15, 2007
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialDeepak L Bhatt, Marcus D Flather, Werner Hacke, et al.JAMA Network Open|August 27, 2021
Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical TrialAndrew C T Ha, Subodh Verma, C David Mazer, et al.European Heart Journal|February 15, 2022
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithmSteven H J Hageman, Ailsa J McKay, Peter Ueda, et al.JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.JAMA|February 10, 2022
Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With AlteplaseWayneho Kam, DaJuanicia N Holmes, Adrian F Hernandez, et al.JAMA|June 20, 2023
Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic StrokeBrian Mac Grory, DaJuanicia N Holmes, Roland A Matsouaka, et al.Pageof 172